Champions Oncology Inc (NAS:CSBR)
$ 8.35 0.25 (3.09%) Market Cap: 114.39 Mil Enterprise Value: 114.98 Mil PE Ratio: 0 PB Ratio: 167.00 GF Score: 66/100

Q4 2020 Champions Oncology Inc Earnings Call Transcript

Jul 27, 2020 / NTS GMT
Release Date Price: $8.95 (-3.97%)
Operator

Greetings and welcome to the Champions Oncology fourth-quarter fiscal year 2020 earnings call. (Operator Instructions) Please note that this conference is being recorded.

I would now turn the conference over to our host, Ronnie Morris, Chief Executive Officer of Champions Oncology. Thank you. You may now begin.

Ronnie Morris
Champions Oncology, Inc. - CEO

Good afternoon. I am Ronnie Morris, the CEO of Champions Oncology. I am joined today by David Miller, our CFO. Thank you for joining us for our fiscal year-end 2020 earnings call.

Before I begin, I will remind you that I will be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements.

Additional information on factors that could cause results to differ is available in our Form 10-Q and Form 10-K. A reconciliation of the non-GAAP financial measures that may be discussed on the call to GAAP financial measures is available in the earnings release.

Overall, we had another year of significant

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot